Osteoporosis
Investigators at Tongji University, Department of Endocrinology have published new data on osteoporosis
Published in Medical Verdicts and Law Weekly, March 11th, 2010
A report, 'A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in China,' is newly published data in Chinese Medical Journal. "Recombinant human parathyroid hormone (1-34) (rhPTH (1-34)) given by injection is a new seventh class drug of biological products, which is prepared by adopting gene recombination technique. rhPTH (1-34) is mainly used to treat osteoporosis, especially for postmenopausal women. This study compared the clinical efficacy and safety of rhPTH (1-34) with elcatonin for treating postmenopausal women with osteoporosis in 11 urban areas of China,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- AARP Idaho
Idaho Health Freedom Act Wrong Rx for State's Health Care Crisis - Agilent Technologies Inc.
Agilent Technologies Wins HPLC Columns Trade Secrets Case Against Advanced Materials Technology, Inc. - Alcohol Monitoring Systems, Inc.
St. Louis County Tests Alcohol Bracelets, Awards Contract to EMASS and SCRAM - Alley Cat Allies
Alley Cat Allies Opposes Illinois Legislation to Cut Spay/Neuter Funding - American Academy of Physician Assistants
Physician Assistants Call on Congress for Policies That Promote High-Quality Patient Care - American Association for Justice
AAJ to Lawmakers: Remember Injured Patients - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
